SQUARE
21.9.2021 09:02:50 CEST | Business Wire | Press release
Today Square, the globally trusted software, payments, and hardware solution for businesses of all sizes, launches in France. Following a successful Early Access Programme , now small businesses and large enterprises across France can access Square’s innovative ecosystem with the tools they need to start, run, grow, and adapt their businesses.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210921005137/en/
“I’ve been using Square’s products both on-site and online over the past few months and it has revolutionised how I run my business,” said Anne-Laure Fonrose, Founder of Tatie Nanna . “Having an integrated, omnichannel payment solution means our customers can pay in any way that suits them. It’s all been easy to set-up and run, the product looks great on site, and the connectivity is super-fast which helps avoid long queues. I’m proud to be using Square as we continue to grow our business.”
French businesses will now have access to a full stack of integrated business tools. Square’s suite of products are designed to seamlessly work with each other to save businesses time and money, reduce inefficiencies from managing multiple systems, and help sellers grow their businesses in the future. Additionally, Square offers fair, transparent, and merchant-friendly pricing for business software and payment processing without requiring any long-term contract or extra fees. Square takes care of fraud prevention, dispute management, security, and compliance at no additional cost. Square’s POS certification also enables merchants to comply with the “Loi anti-fraude TVA, 20181 ”. Businesses can access their funds as soon as the next working day and only pay a transaction fee when they accept a card or mobile payment.
“International growth has been a key priority this year, and we’re proud to officially launch in France as our third European market,” said Alyssa Henry, Executive Vice President at Square. “Sellers around the country will now be able to use our omnichannel ecosystem of products and services, allowing business owners to focus on running their business.”
“We are thrilled to expand Square’s solutions into France, helping merchants to run their entire business end-to-end with integrated software, hardware, and data analytics, while making it easier for them to take card payments,” said Jason Lalor, European Executive Director at Square. “French businesses can trust Square to be a fair, transparent, and innovative partner they can rely on to help them run their business and get back-on-track after times of uncertainty.”
French businesses can now sell online, in-person, or both with Square’s integrated suite of products, including:
-
Point of sale and payments software and hardware to suit any business:
Square launches with two point of sale software products and three versatile payment terminals in France offering both mobile and brick & mortar businesses fully integrated POS software, reliable and secure payments acceptance, and one transparent processing rate of 1.65% for all card-present transactions. With no long-term contracts or monthly fees, the systems are designed for you and your employees to get started quickly.
- Square Point of Sale is the trusted solution used by business owners around the world to process payments, sell anywhere, and manage their customer base. With fast checkout flows, built-in customer management, and intuitive sales reporting, Square Point of Sale makes it easy to run a business customers love.
- Square for Restaurants helps businesses by offering an integrated set of industry-specific tools and POS for food and beverage merchants that would ordinarily require multiple vendors, all under one umbrella.
- Square Terminal, Square Stand, and Square Reader are versatile, easy-to-set-up devices. For a limited time, Square Terminal will be priced at 99 € (usually 165 €), Square Stand will be 79 € (usually 139 €), and Square Reader will be completely free (usually 19 €) – all available on Square Shop . This pricing is limited to one device per merchant.
- Square Online: Square’s fully integrated e-commerce platform that automatically syncs inventory and orders with any Square point of sale makes it seamless for any business to expand through omnichannel selling. Square Online supports sellers across a variety of verticals: from easily enabling click-and-collect for local business, to a QR code dining platform allowing diners to order and pay from their mobile device, to a full ecommerce website with social media integrations for retail. Square Online offers a feature-rich free plan as well as a variety of paid subscription plans and payment processing is competitively priced at 1.4% + 25c per transaction for EU cards.
-
Robust business tools to power operations:
Square manages the behind-the-scenes details, giving time back to merchants to focus on running their business. Tools include:
- Online Checkout, to quickly sell online via embeddable buy buttons and payment links
- Virtual Terminal, to use your computer to take payments remotely
- Team Management, to streamline timecards and staffing
- Kitchen Display System, to expedite your kitchen operations – including delivery orders
- eGift Cards, to provide an additional way to reach customers
- Square Invoices will launch later this year to help businesses send professional, digital estimates and invoices and get paid faster
- Partner platform to unlock even more functionality: Square integrates with business tools like Prestashop, Wix, Bookeo and Deliverect to enable businesses to use Square seamlessly with third-party software that caters to their specific needs.
- Suite of API’s enabling developers to create solutions for sellers: Our APIs and SDKs enable developers to build custom applications that can seamlessly integrate with the rest of our ecosystem of products.
Businesses interested in learning more about getting started with Square can visit: https://squareup.com/fr
About Square, Inc.
Square, Inc. (NYSE: SQ) builds tools to empower businesses and individuals to participate in the economy. Sellers use Square to reach buyers online and in person, manage their business, and access financing. Individuals use Cash App to spend, send, store, and invest money. And TIDAL is a global music and entertainment platform that expands Square's purpose of economic empowerment to artists. Square, Inc. has offices in the United States, Canada, Japan, Australia, Ireland, Spain, Norway, and the UK.
1 On 24 October 2018, the French Anti-Fraud Act1 (loi relative à la lutte contre la fraude, the Act) was published in the Official Journal (OJ). The Act was designed to strengthen the measures to fight against taxpayers’ failure to comply with their tax and social duties.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210921005137/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
